AEON BIOPHARMA Trademark

Trademark Overview

On Monday, September 23, 2019, a trademark application was filed for AEON BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the AEON BIOPHARMA trademark a serial number of 88626873. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, February 27, 2024. This trademark is owned by AEON Biopharma, Inc.. The AEON BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal conditions; Pharmaceutical preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use
aeon biopharma

General Information

Serial Number88626873
Word MarkAEON BIOPHARMA
Filing DateMonday, September 23, 2019
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological conditions; Pharmaceutical preparations for the treatment of gastrointestinal conditions; Pharmaceutical preparations for the treatment of neurologic and psychiatric disorders; botulinum toxins for therapeutic use
Disclaimer with Predetermined Text"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAEON Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, February 9, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, July 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 31, 2023LETTER OF SUSPENSION E-MAILED
Monday, July 31, 2023SUSPENSION LETTER WRITTEN
Wednesday, June 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 28, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 28, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, July 22, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 18, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 3, 2022ASSIGNED TO EXAMINER
Thursday, July 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, July 18, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, July 18, 2020LETTER OF SUSPENSION E-MAILED
Saturday, July 18, 2020SUSPENSION LETTER WRITTEN
Tuesday, June 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 31, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 31, 2019NON-FINAL ACTION E-MAILED
Tuesday, December 31, 2019NON-FINAL ACTION WRITTEN
Monday, December 23, 2019ASSIGNED TO EXAMINER
Friday, September 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2019NEW APPLICATION ENTERED

Related Keywords

biopharma aeon pharmaceutical treatment preparations conditions botulinum toxins therapeutic disorders gastrointestinal neurological